Preliminary experiments indicate conolidine might inhibit specific ion channels, decreasing neuronal excitability and restricting suffering alerts. This mechanism is particularly relevant in neuropathic ache, in which abnormal signaling brings about persistent pain. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to discomfort perception. ... https://jamesv415tag9.blogunok.com/profile